HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

2 days ago

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia assessment The Company is gearing…

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

2 days ago

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

2 days ago

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which helps childhood cancer survivors pursue…

Honeycomb Clinic Positions for Public Offering

2 days ago

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024 / Honeycomb Clinic, the innovative…

Ensysce Biosciences Regains Full Compliance with Nasdaq

2 days ago

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical…

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

2 days ago

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the "Company", an emerging leader in…

Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone

2 days ago

With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months…

NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape

2 days ago

SHELTON, CT / ACCESSWIRE / December 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), says that its broad-spectrum antiviral…

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds

2 days ago

– Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators LA JOLLA,…

XBiotech Pauses Rheumatology program

2 days ago

Findings from recently completed Rheumatoid Arthritis Study raise questionsAUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today…